Clinical Trials List
2014-09-01 - 2018-11-30
Phase III
Terminated10
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chao-Hua Chiu Division of Hematology & Oncology
- 蔡俊明 Division of Hematology & Oncology
- Yung-Hung Luo Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 蘇健 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Fu-Tsai Chung Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chih-Yen Tu Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- Wei-Chun Chen Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 趙東瀛 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 張晃志 醫師 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- CHIN-CHOU WANG Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wei-Hwa Lee Division of Thoracic Medicine
- Tsu-Yi Chao Division of Thoracic Medicine
- Tzu-Tao Chen Division of Thoracic Medicine
- TSU-YI CHAO Division of Thoracic Medicine
- Yao-Yu Hsieh Division of Thoracic Medicine
- 蘇勇誠 Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
2500 participants
